The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions
In recent years, the application of fixed dose combinations of antiretroviral drugs in HIV therapy has been established. Despite numerous therapeutic benefits, this approach poses several challenges for the formulation development especially when poorly soluble drugs are considered. Amorphous solid...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | International Journal of Pharmaceutics: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259015672400015X |
| _version_ | 1827221863478067200 |
|---|---|
| author | Marcel Kokott Jörg Breitkreutz Raphael Wiedey |
| author_facet | Marcel Kokott Jörg Breitkreutz Raphael Wiedey |
| author_sort | Marcel Kokott |
| collection | DOAJ |
| description | In recent years, the application of fixed dose combinations of antiretroviral drugs in HIV therapy has been established. Despite numerous therapeutic benefits, this approach poses several challenges for the formulation development especially when poorly soluble drugs are considered. Amorphous solid dispersions (ASD) thereby have gained considerable interest in the pharmaceutical field, however, mainly including binary systems containing only one drug and a polymer. The co-formulation of two amorphous drugs can be accompanied by an immense increase in the complexity of the system as exemplarily reported for ritonavir and lopinavir embedded in a composite polymer matrix of PVPVA. The present study aims to present a new formulation approach to overcome the well-documented interaction during dissolution. Two different polymers, PVPVA and HPMCAS were used to produce ASDs for both drugs individually via hot-melt extrusion. The embedding of lopinavir in the slower dissolving polymer HPMCAS, while using PVPVA for ritonavir was found to significantly improve the overall dissolution performance compared to the individual use of PVPVA as well as to the commercial product Kaletra®. In addition, the use of different grades of HPMCAS demonstrated the possibility to further modify the dissolution profile. For a preliminary biorelevant assessment, the selected formulations were tested in a biphasic dissolution setup. |
| first_indexed | 2024-04-24T13:11:13Z |
| format | Article |
| id | doaj.art-f2c5c13701a946a6acaf16b1364a3906 |
| institution | Directory Open Access Journal |
| issn | 2590-1567 |
| language | English |
| last_indexed | 2025-03-21T16:29:21Z |
| publishDate | 2024-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | International Journal of Pharmaceutics: X |
| spelling | doaj.art-f2c5c13701a946a6acaf16b1364a39062024-06-17T05:56:40ZengElsevierInternational Journal of Pharmaceutics: X2590-15672024-06-017100243The interplay of poorly soluble drugs in dissolution from amorphous solid dispersionsMarcel Kokott0Jörg Breitkreutz1Raphael Wiedey2Corresponding author.; Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Duesseldorf Universitaetsstr. 1, Duesseldorf 40225, GermanyInstitute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Duesseldorf Universitaetsstr. 1, Duesseldorf 40225, GermanyInstitute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Duesseldorf Universitaetsstr. 1, Duesseldorf 40225, GermanyIn recent years, the application of fixed dose combinations of antiretroviral drugs in HIV therapy has been established. Despite numerous therapeutic benefits, this approach poses several challenges for the formulation development especially when poorly soluble drugs are considered. Amorphous solid dispersions (ASD) thereby have gained considerable interest in the pharmaceutical field, however, mainly including binary systems containing only one drug and a polymer. The co-formulation of two amorphous drugs can be accompanied by an immense increase in the complexity of the system as exemplarily reported for ritonavir and lopinavir embedded in a composite polymer matrix of PVPVA. The present study aims to present a new formulation approach to overcome the well-documented interaction during dissolution. Two different polymers, PVPVA and HPMCAS were used to produce ASDs for both drugs individually via hot-melt extrusion. The embedding of lopinavir in the slower dissolving polymer HPMCAS, while using PVPVA for ritonavir was found to significantly improve the overall dissolution performance compared to the individual use of PVPVA as well as to the commercial product Kaletra®. In addition, the use of different grades of HPMCAS demonstrated the possibility to further modify the dissolution profile. For a preliminary biorelevant assessment, the selected formulations were tested in a biphasic dissolution setup.http://www.sciencedirect.com/science/article/pii/S259015672400015XFixed dose combinationAmorphous solid dispersionRitonavirLopinavirBiorelevant dissolutionPoorly water soluble drugs |
| spellingShingle | Marcel Kokott Jörg Breitkreutz Raphael Wiedey The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions International Journal of Pharmaceutics: X Fixed dose combination Amorphous solid dispersion Ritonavir Lopinavir Biorelevant dissolution Poorly water soluble drugs |
| title | The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions |
| title_full | The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions |
| title_fullStr | The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions |
| title_full_unstemmed | The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions |
| title_short | The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions |
| title_sort | interplay of poorly soluble drugs in dissolution from amorphous solid dispersions |
| topic | Fixed dose combination Amorphous solid dispersion Ritonavir Lopinavir Biorelevant dissolution Poorly water soluble drugs |
| url | http://www.sciencedirect.com/science/article/pii/S259015672400015X |
| work_keys_str_mv | AT marcelkokott theinterplayofpoorlysolubledrugsindissolutionfromamorphoussoliddispersions AT jorgbreitkreutz theinterplayofpoorlysolubledrugsindissolutionfromamorphoussoliddispersions AT raphaelwiedey theinterplayofpoorlysolubledrugsindissolutionfromamorphoussoliddispersions AT marcelkokott interplayofpoorlysolubledrugsindissolutionfromamorphoussoliddispersions AT jorgbreitkreutz interplayofpoorlysolubledrugsindissolutionfromamorphoussoliddispersions AT raphaelwiedey interplayofpoorlysolubledrugsindissolutionfromamorphoussoliddispersions |